INBS·36151G709·US·equity·Healthcare - Medical Devices-13D/G
INBS (INTELLIGENT BIO SOLUTIONS IN) is held by 4 institutional investors as of Q1 2026. Largest holders: Alyeska Investment Group, L.P. ($126,963), GEODE CAPITAL MANAGEMENT, LLC ($95,696), UBS Group AG ($1,244). Net institutional sentiment: Mixed.
See how INBS's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer